Updated:
Tiger Jade Capital
Tiger Jade Capital is a private equity fund focused on the global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical...
Overview
Tiger Jade Capital is a private equity fund focused on the global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, and related areas. The firm aspires to aggregate conscious capital to improve people’s well being and deliver optimal returns for investors.
General information
Firm type
Private Equity
Year founded
2019
Location
Region
Asia
Country
Hong Kong
City
Hong Kong
Corporate office
Hong Kong, Hong Kong
Principals
Jasper Jiang
Founding Partner
Stacey Ying Liu
Founding Partner
Emmanuel Hui
Principal
Dr. Xiaoping Ye
Senior Advisor of Investment Committee
Sector focus
Frequently asked questions
What investment stages does Tiger Jade Capital target?
Tiger Jade Capital deploys capital from seed and start-up stage through to pre-IPO rounds, according to the firm's disclosed strategy. This full-lifecycle approach means the firm can enter at a company's earliest funding rounds and maintain its position through later growth-stage financings. The structure avoids the typical hand-off between early-stage and growth-stage investors.
Does Tiger Jade Capital invest only in Asia-based companies?
Tiger Jade is headquartered in Hong Kong and positions itself as an Asia-focused private equity firm. The firm has not published a geographic mandate document, but its Hong Kong base and regional framing suggest portfolio companies are predominantly Asia-headquartered or generate the bulk of their revenue within Asia.
Is Tiger Jade Capital structured as a venture capital firm or a private equity firm?
Tiger Jade describes itself as a private equity firm, but its strategy spans early-stage venture and pre-IPO growth equity. This is more accurately a full-lifecycle private investment model than a pure venture capital or buyout approach. The firm's mandate allows it to hold positions from a company's first institutional round through to public listing.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: